12/23/24 16:39 | 12/23/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -246 | 19.59 | 0 | -13 | 0 | 3,776 | D | | | | | | | | | | | | | | |
12/20/24 18:04 | 12/18/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -567 | 21.24 | 0 | -27 | -1 | 3,788 | D | | | | | | | | | | | | | | |
2/2/24 17:25 | 1/31/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 836 | 14.54 | 0 | 57 | 2 | 3,715 | D | | | | | | | | | | | | | | |
2/2/24 17:25 | 1/31/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.d | -1,860 | 32.35 | 0 | -57 | -2 | 3,715 | D | | | | | | | | | | | | | | |
1/4/24 17:25 | 1/2/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -309 | 31.01 | 0 | -10 | 0 | 3,715 | D | | | | | | | | | | | | | | |
12/22/23 17:04 | 12/20/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -342 | 28.54 | 0 | -12 | 0 | 3,725 | D | | | | | | | | | | | | | | |
10/27/23 18:23 | 10/25/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -589 | 24.21 | 0 | -24 | -1 | 3,737 | D | | | | | | | | | | | | | | |
9/20/23 18:10 | 9/18/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 274 | 4.75 | 0 | 58 | 2 | 3,761 | D | | | | | | | | | | | | | | |
9/20/23 18:10 | 9/18/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.d | -1,624 | 28.12 | 0 | -58 | -2 | 3,761 | D | | | | | | | | | | | | | | |
5/5/23 19:04 | 5/3/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.dm | 211 | 2.01 | 0 | 105 | 3 | 3,761 | D | | | | | | | | | | | | | | |
5/5/23 19:04 | 5/3/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.dm | -4,126 | 39.32 | 0 | -105 | -3 | 3,761 | D | | | | | | | | | | | | | | |
9/29/22 17:15 | 9/27/22 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M | 1,251 | 30.79 | 0 | 41 | 1 | 3,468 | D | | | | | | | | | | | | | | |
7/11/22 20:08 | 7/7/22 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 36 | 14.54 | 0 | 3 | 0 | 4,060 | D | | | | | | | | | | | | | | |